--- source_url: https://hangovr180.com/science/claims/aldehyde-metabolism.md canonical_url: https://hangovr180.com/science/claims/aldehyde-metabolism generated_at: 2026-06-28T19:53:17Z build_id: ebfcfef page_type: science-leaf claim_ids: [SF-22, SF-21, SF-20] --- # ALDEHYDE METABOLISM EXPLAINED *The headline structure-function claim H180 makes is about aldehyde metabolism, and that claim ties to a well-described two-enzyme pathway in the liver that the research literature has mapped end-to-end.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. ## The Two-Enzyme Pathway When you drink, alcohol dehydrogenase (ADH) converts ethanol into acetaldehyde, then aldehyde dehydrogenase (ALDH) converts acetaldehyde into acetate, which the body then breaks down into water and carbon dioxide and clears out [1]. The pathway is short, the chemistry is well-mapped, and the rate-limiting step is usually ALDH, which is why genetic ALDH2 variants produce the dramatic flushing response in some populations -- the system can make acetaldehyde quickly but cannot clear it efficiently [2]. Acetaldehyde is the problem molecule in this sequence. It is a known carcinogen, it binds readily to proteins and DNA, and most of the next-morning damage people associate with drinking traces back to acetaldehyde rather than to ethanol itself [1]. ## What the DHM Mechanism Does to the Pathway > **Claim [SF-22]:** Triggers the liver to produce more of the aldehyde- and alcohol-metabolizing enzymes (ADH and ALDH) and boosts their efficiency in breaking down aldehydes and alcohols in foods as well as their by-products. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The DHM enzyme-induction story is the foundation of this claim. The Shen 2012 paper from UCLA showed DHM induces ADH1 and ALDH2 expression in rat liver, restores depleted NAD+ cofactor levels, and reduces serum ethanol and acetaldehyde concentrations after alcohol challenge [3]. A 2020 follow-up confirmed the induction story and added detail on the lipid-metabolism downstream effects [4]. The enzyme-induction effect is reproducible across multiple labs, in the published rodent data at least. (this claim does the most regulatory work for us, because it is the claim that maps most directly to a published animal mechanism.) ## What "Promoting Aldehyde and Alcohol Metabolism" Means > **Claim [SF-21]:** Acts by promoting aldehyde and alcohol metabolism of foods. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The "promoting" language is the DSHEA-compliant phrasing for what the published animal data actually shows. DHM increases the expression and activity of the enzymes that perform aldehyde and alcohol metabolism. The mechanism is upregulation, not replacement -- DHM does not metabolize ethanol itself, it makes the cell's own enzymatic machinery do it faster. The "of foods" language matters legally. Structure-function claims under DSHEA cannot describe disease treatment, so the claim is framed around the metabolism of compounds present in foods (which alcohol technically is, in regulatory terms) rather than around any clinical hangover endpoint. ## The AST/ALT Claim > **Claim [SF-20]:** Lowers liver enzyme (AST and ALT) levels that are already in the normal range. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. AST and ALT are serum markers of hepatocellular stress. When DHM is administered to animals during ethanol exposure, AST and ALT levels move toward normal compared to ethanol-only controls -- the hepatoprotective effect that comes from faster acetaldehyde clearance and reduced collateral oxidative damage [4]. The AST/ALT claim is bounded to values already in teh normal range, which is the DSHEA-compliant way to phrase a structure-function effect on liver enzyme markers without crossing into disease-treatment territory. ## What This Page Is Not Claiming The aldehyde-metabolism claim is not "DHM is a hangover cure" or "DHM allows you to drink more." The mechanism shifts the curve of acetaldehyde clearance, and the cumulative consequence in animals is reduced hepatic stress markers, but the published human clinical literature on DHM specifically for hangover endpoints is still thin. The claim is what the mechanism literature supports, framed in DSHEA-compliant terms. For the full mechanism in detail, see [How DHM Works -- The ADH/ALDH Pathway](/science/dhm/adh-aldh-pathway). For the closely related liver-detoxification claim, see [The Liver Detoxification Claim](/science/claims/liver-detoxification). ## Citations 1. [Alcohol Metabolism (NIAAA)](https://www.niaaa.nih.gov/publications/alcohol-metabolism). niaaa.nih.gov. 2. [The Genetics of Alcohol Metabolism -- Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants](https://pmc.ncbi.nlm.nih.gov/articles/PMC3860432/). pmc.ncbi.nlm.nih.gov. 3. [Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication](https://pmc.ncbi.nlm.nih.gov/articles/PMC3292407/). pmc.ncbi.nlm.nih.gov. 4. [Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism](https://pmc.ncbi.nlm.nih.gov/articles/PMC7211127/). pmc.ncbi.nlm.nih.gov. ## Read Next - [How DHM Works -- The ADH/ALDH Pathway](/science/dhm/adh-aldh-pathway) - [The Liver Detoxification Claim](/science/claims/liver-detoxification) - [Alcohol Metabolism Explained](/science/context/alcohol-metabolism-explained) - [The Claims -- The Hub](/science/claims) **Written by Mark Scott** - Co-Formulator, Hangovr180® | Co-Inventor, [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1) Mark Scott conducted approximately 150 personal formulation tests over six months to develop the H180 ingredient combination. [Editorial standards](/editorial-standards) --- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Hangovr180® is a dietary supplement. Individual results may vary. Consult your healthcare provider before use if you have any medical conditions or take medications. [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1). Canonical: https://hangovr180.com/science/claims/aldehyde-metabolism